We are live on ! Find out more
EVGN icon

Evogene
EVGN

24 hedge funds and large institutions have $28.8M invested in Evogene in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

26% more funds holding

Funds holding: 19 → 24 (+5)

4.87% more ownership

Funds ownership: 30.94% → 35.81% (+4.9%)

25% less capital invested

Capital invested by funds: $38.3M → $28.8M (-$9.55M)

Holders
24
Holders Change
+5
Holders Change %
+26.32%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.71M
2
HIIFS
Harel Insurance Investments & Financial Services
Israel
+$542K
3
MCM
Moon Capital Management
New York
+$470K
4
JP Morgan Chase
JP Morgan Chase
New York
+$295K
5
Jane Street
Jane Street
New York
+$267K

Top Sellers

Rank Fund Capital Flow
1
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$118K
2
SWM
Stockman Wealth Management
Montana
-$18K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4K

EVGN Hedge Fund Activity: Q4 2017 in Review

24 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2017, worth a combined $28.8M — down 25% from $38.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new EVGN positions and 1 closed out — a net gain of 5 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.71M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $118K.

  • 24 institutional investors held Evogene (EVGN) as of Q4 2017, up from 19 in Q3 2017.
  • Funds reported $28.8M of Evogene stock for Q4 2017, down 25% quarter-over-quarter.
  • 6 funds opened new Evogene positions in Q4 2017 and 1 closed out, a net change of +5 holders.
  • The largest Evogene buyer in Q4 2017 was Morgan Stanley, an estimated $1.71M added.
  • The largest Evogene seller in Q4 2017 was Canada Pension Plan Investment Board, an estimated $118K sold.

Based on aggregated 13F filings for Q4 2017.